The at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is likely to surpass US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increased infectious illnesses and an increase in the number of diabetes patients around the world are driving the market expansion. For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness of them are fueling market expansion.
The prospective growth of the at-home testing market was influenced by the population's growing awareness of home care testing.
Other Drivers Propelling the Demand for At-home Molecular Testing Market include:
Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:
Opportunities in the At-home Molecular Testing Market Industry:
Latest Trends in the At-home Molecular Testing Market:
| Attributes | Details |
|---|---|
| At-home Molecular Testing Market Size (2023) | US$ 10.2 billion |
| At-home Molecular Testing Market Projected Size (2033) | US$ 18.1 billion |
| Value CAGR (2023 to 2033) | 5.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global at-home molecular testing market experienced a CAGR of 5.4%, reaching a market size of US$ 10.2 billion in 2023.
From 2017 to 2022, the global at-home molecular testing market industry witnessed steady growth due to the increased awareness and acceptance of at-home molecular testing. The at-home molecular testing market was in its infancy, primarily focused on genetic testing for ancestry and genealogy purposes. Companies like 23andMe and AncestryDNA gained popularity, attracting consumers interested in exploring their genetic heritage. The market witnessed increased awareness and acceptance of at-home molecular testing during this period. More consumers recognized the potential benefits of understanding their genetic health risks and gaining personalized insights. The market diversified to include tests for traits, wellness, and lifestyle factors, such as diet and exercise recommendations based on genetic profiles.
Future Forecast for At-home Molecular Testing Market Industry:
Looking ahead, the global at-home molecular testing market industry is expected to rise at a CAGR of 5.9% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 18.1 billion by 2033.
The at-home molecular testing market industry is expected to continue its growth trajectory from 2023 to 2033. The at-home molecular testing market is expected to witness an expansion of the test menu, offering a wider range of genetic and molecular tests. As scientific knowledge expands, more disease markers, genetic variants, and actionable insights will be identified, leading to the development of new tests. This diversification will attract a larger consumer base and drive market growth.
The growing focus on personalized medicine and preventive healthcare will fuel the demand for at-home molecular testing. Individuals are increasingly interested in understanding their genetic predispositions, optimizing their health choices, and monitoring disease risks. At-home testing provides a convenient and accessible means to achieve these goals.
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 5.6 billion |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The at-home molecular testing market industry in the United States is expected to reach a market size of US$ 5.6 billion by 2033, expanding at a CAGR of 7.2%. Due to the rising demand for at home diabetic testing kits. In the United States, more than 130 million persons have diabetes or prediabetes, according to the Centers for Disease Control and Prevention 2022. Such growing prevalence of diabetes in the country, the demand for at home molecular testing market is high.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 689.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The at-home molecular testing market industry in the United Kingdom is expected to reach a market share of US$ 689.1 million, expanding at a CAGR of 6.8% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing personalized medicine initiatives. The United Kingdom has been at the forefront of personalized medicine initiatives, aiming to provide tailored healthcare based on an individual's genetic profile. At-home molecular testing plays a crucial role in these initiatives, allowing individuals to access genetic information, identify disease risks, and participate in research studies to advance personalized healthcare.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 1.30 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.1% |
The at-home molecular testing market industry in China is anticipated to reach a market size of US$ 1.30 billion, moving at a CAGR of 5.1% during the forecast period. The at-home molecular testing market industry in China is expected to grow prominently due to the increasing chronic disease. China is facing a rising burden of chronic diseases, such as cardiovascular diseases, diabetes, and cancer. At-home molecular testing offers a way for individuals to monitor their health, detect diseases early, and take preventive measures. The ability to access testing from the comfort of their homes aligns with the increasing emphasis on preventive healthcare.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 1.12 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.8% |
The at-home molecular testing market industry in Japan is estimated to reach a market size of US$ 1.12 billion by 2033, thriving at a CAGR of 5.8%. The market in Japan is predicted to grow because of the growing technological advancements. Japan has a well-established e-commerce infrastructure and a high penetration of smartphones. This has facilitated the growth of online platforms and marketplaces for at-home molecular testing kits. The ease of purchasing and accessing these kits online has contributed to the rising demand in the country.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 253.9 million |
| CAGR % 2023 to End of Forecast (2033) | 3.6% |
The at-home molecular testing market industry in South Korea is expected to reach a market size of US$ 253.9 million, expanding at a CAGR of 3.6% during the forecast period. The market in South Korea is forecasted to witness growth due to the increased awareness and acceptance. There has been a growing awareness and acceptance of at-home molecular testing among the general population in the South Korea. Consumers are increasingly interested in understanding their genetic heritage, health risks, and ancestry. This has contributed to the rising demand for at-home genetic testing kits.
Principal Consultant
The cassettes are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 due to its rapid testing procedures, high efficiency, and improved testing kits.
According to the needs of the consumer, diagnostic cassettes for rapid test for diagnostic kits can be used in a single way or many ways (two or four ways). For immediate results, Plastic Cassettes for Rapid Test (Cassettes for Diagnostic Kits) are frequently utilized. For the best outcomes, it also guarantees improved buffer flow with the right pressure points through the strip.
Infectious diseases are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 as incidences of infectious diseases in the globe is on the rise.
The prevalence of infectious diseases in developed and developing regions will have a beneficial impact on market growth. The increasing number of prescriptions for at-home infectious illness diagnostic tests is due to the diagnosis and management of such infections.
The blood sample segment is expected to dominate the at-home molecular testing market industry with a CAGR of 5.5% from 2023 to 2033 and is expected to hold market share of 42.4% in 2023. Blood testing are extremely common. They aid clinicians in the detection of certain diseases and ailments. They also aid in the evaluation of organ function and the effectiveness of treatments. One of the most popular blood tests is the complete blood count (CBC). It is frequently performed as part of a standard checkup. This test evaluates a variety of blood components, including red blood cells, white blood cells, and platelets.
The drug store in dominating the at home molecular testing market with the CAGR of 6.2%. The ease of availability of the testing kits without prescription in the drug store the adoption is high.
The at-home molecular testing sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
The market for at-home molecular testing is rising quickly in developing nations like China and India. To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.
Key companies in the at-home molecular testing market routinely employ mergers and acquisitions to strengthen their market positions, broaden their product offerings, and enter new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the At-home Molecular Testing Market:
The at-home molecular testing market CAGR for 2033 is 5.9%.
The North America region is the leading region in the market.
The projected market value of the market for 2033 is US$ 10.2 billion.
Key players are developing the market by developing innovative tests.
China, India, the United States, Japan, and Germany are the major countries in this market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USPs
4.3. Technological Roadmap
4.4. Recent Product Approvals/Launces
4.5. Reimbursement Scenario
4.6. Regulatory Landscape
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Increasing Cases of Infectious Diseases
5.2.3. Favourable Government Regulations
5.2.4. Rising Demand for At Home Kits
5.2.5. Technological Advancement in the Devices
5.2.6. Increasing Prevalence of Diabetes
5.2.7. Growing Product Demand For Genetic Predispositions
5.2.8. Increasing Product Approvals/Launches
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2017 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Cassettes
9.3.2. Strips
9.3.3. Test Panels
9.3.4. Dip Cards
9.3.5. Midstreams
9.3.6. Others
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Test Type, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
10.3.1. Pregnancy Tests
10.3.2. HIV Tests
10.3.3. Diabetes
10.3.4. Infectious Diseases
10.3.5. Glucose Tests
10.3.6. Ovulation Predictor Tests
10.3.7. Drug Abuse Tests
10.3.8. Others
10.4. Market Attractiveness Analysis By Test Type
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033
11.3.1. Urine
11.3.2. Blood
11.3.3. Saliva
11.3.4. Others
11.4. Market Attractiveness Analysis By Sample Type
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
12.3.1. Retail Pharmacies
12.3.2. Drug Stores
12.3.3. Supermarkets/Hypermarkets
12.3.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Sample Type
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Test Type
14.4.4. By Sample Type
14.4.5. By Distribution Channel
14.5. Country Level Analysis & Forecast
14.5.1. USA Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Test Type
14.5.1.2.3. By Sample Type
14.5.1.2.4. By Distribution Channel
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Test Type
14.5.2.2.3. By Sample Type
14.5.2.2.4. By Distribution Channel
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Sample Type
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Test Type
15.4.4. By Sample Type
15.4.5. By Distribution Channel
15.5. Country Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Test Type
15.5.1.2.3. By Sample Type
15.5.1.2.4. By Distribution Channel
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Test Type
15.5.2.2.3. By Sample Type
15.5.2.2.4. By Distribution Channel
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Test Type
15.5.3.2.3. By Sample Type
15.5.3.2.4. By Distribution Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. UK
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Test Type
16.3.4. By Sample Type
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Test Type
16.4.4. By Sample Type
16.4.5. By Distribution Channel
16.5. Country Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Test Type
16.5.1.2.3. By Sample Type
16.5.1.2.4. By Distribution Channel
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Test Type
16.5.2.2.3. By Sample Type
16.5.2.2.4. By Distribution Channel
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Test Type
16.5.3.2.3. By Sample Type
16.5.3.2.4. By Distribution Channel
16.5.4. UK Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Test Type
16.5.4.2.3. By Sample Type
16.5.4.2.4. By Distribution Channel
16.5.5. Spain Market Analysis
16.5.5.1. Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Product
16.5.5.2.2. By Test Type
16.5.5.2.3. By Sample Type
16.5.5.2.4. By Distribution Channel
16.5.6. Russia Market Analysis
16.5.6.1. Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product
16.5.6.2.2. By Test Type
16.5.6.2.3. By Sample Type
16.5.6.2.4. By Distribution Channel
16.5.7. BENELUX Market Analysis
16.5.7.1. Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product
16.5.7.2.2. By Test Type
16.5.7.2.3. By Sample Type
16.5.7.2.4. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Test Type
17.3.4. By Sample Type
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Test Type
17.4.4. By Sample Type
17.4.5. By Distribution Channel
17.5. Country Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Test Type
17.5.1.2.3. By Sample Type
17.5.1.2.4. By Distribution Channel
17.5.2. Thailand Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Test Type
17.5.2.2.3. By Sample Type
17.5.2.2.4. By Distribution Channel
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Test Type
17.5.3.2.3. By Sample Type
17.5.3.2.4. By Distribution Channel
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Product
17.5.4.2.2. By Test Type
17.5.4.2.3. By Sample Type
17.5.4.2.4. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Test Type
18.3.4. By Sample Type
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Test Type
18.4.4. By Sample Type
18.4.5. By Distribution Channel
18.5. Country Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Test Type
18.5.1.2.3. By Sample Type
18.5.1.2.4. By Distribution Channel
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Test Type
18.5.2.2.3. By Sample Type
18.5.2.2.4. By Distribution Channel
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Test Type
18.5.3.2.3. By Sample Type
18.5.3.2.4. By Distribution Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Test Type
19.3.4. By Sample Type
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Test Type
19.4.4. By Sample Type
19.4.5. By Distribution Channel
19.5. Country Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Test Type
19.5.1.2.3. By Sample Type
19.5.1.2.4. By Distribution Channel
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Test Type
19.5.2.2.3. By Sample Type
19.5.2.2.4. By Distribution Channel
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Test Type
20.3.4. By Sample Type
20.3.5. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Test Type
20.4.4. By Sample Type
20.4.5. By Distribution Channel
20.5. Country Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Test Type
20.5.1.2.3. By Sample Type
20.5.1.2.4. By Distribution Channel
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Test Type
20.5.2.2.3. By Sample Type
20.5.2.2.4. By Distribution Channel
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Test Type
20.5.3.2.3. By Sample Type
20.5.3.2.4. By Distribution Channel
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Product
20.5.4.2.2. By Test Type
20.5.4.2.3. By Sample Type
20.5.4.2.4. By Distribution Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. Abbott
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategy
22.4.1.6.2. Product Strategy
22.4.1.6.3. Channel Strategy
22.4.2. Rapikit
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financials
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategy
22.4.2.6.2. Product Strategy
22.4.2.6.3. Channel Strategy
22.4.3. Becton and Dickinson
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financials
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategy
22.4.3.6.2. Product Strategy
22.4.3.6.3. Channel Strategy
22.4.4. Cardinal Health
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financials
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategy
22.4.4.6.2. Product Strategy
22.4.4.6.3. Channel Strategy
22.4.5. B. Braun Melsungen AG
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Key Financials
22.4.5.4. Sales Footprint
22.4.5.5. SWOT Analysis
22.4.5.6. Strategy Overview
22.4.5.6.1. Marketing Strategy
22.4.5.6.2. Product Strategy
22.4.5.6.3. Channel Strategy
22.4.6. Piramal Enterprises Ltd.
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financials
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategy
22.4.6.6.2. Product Strategy
22.4.6.6.3. Channel Strategy
22.4.7. Siemens Healthcare GmbH
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financials
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategy
22.4.7.6.2. Product Strategy
22.4.7.6.3. Channel Strategy
22.4.8. Quidel Corporation
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Key Financials
22.4.8.4. Sales Footprint
22.4.8.5. SWOT Analysis
22.4.8.6. Strategy Overview
22.4.8.6.1. Marketing Strategy
22.4.8.6.2. Product Strategy
22.4.8.6.3. Channel Strategy
22.4.9. Bionime Corporation
22.4.9.1. Overview
22.4.9.2. Product Portfolio
22.4.9.3. Key Financials
22.4.9.4. Sales Footprint
22.4.9.5. SWOT Analysis
22.4.9.6. Strategy Overview
22.4.9.6.1. Marketing Strategy
22.4.9.6.2. Product Strategy
22.4.9.6.3. Channel Strategy
22.4.10. SA Scientific
22.4.10.1. Overview
22.4.10.2. Product Portfolio
22.4.10.3. Key Financials
22.4.10.4. Sales Footprint
22.4.10.5. SWOT Analysis
22.4.10.6. Strategy Overview
22.4.10.6.1. Marketing Strategy
22.4.10.6.2. Product Strategy
22.4.10.6.3. Channel Strategy
22.4.11. ARKRAY USA, Inc.
22.4.11.1. Overview
22.4.11.2. Product Portfolio
22.4.11.3. Key Financials
22.4.11.4. Sales Footprint
22.4.11.5. SWOT Analysis
22.4.11.6. Strategy Overview
22.4.11.6.1. Marketing Strategy
22.4.11.6.2. Product Strategy
22.4.11.6.3. Channel Strategy
22.4.12. Nova Biomedical
22.4.12.1. Overview
22.4.12.2. Product Portfolio
22.4.12.3. Key Financials
22.4.12.4. Sales Footprint
22.4.12.5. SWOT Analysis
22.4.12.6. Strategy Overview
22.4.12.6.1. Marketing Strategy
22.4.12.6.2. Product Strategy
22.4.12.6.3. Channel Strategy
22.4.13. AdvaCare Pharma
22.4.13.1. Overview
22.4.13.2. Product Portfolio
22.4.13.3. Key Financials
22.4.13.4. Sales Footprint
22.4.13.5. SWOT Analysis
22.4.13.6. Strategy Overview
22.4.13.6.1. Marketing Strategy
22.4.13.6.2. Product Strategy
22.4.13.6.3. Channel Strategy
22.4.14. AccuBioTech Co., Ltd.
22.4.14.1. Overview
22.4.14.2. Product Portfolio
22.4.14.3. Key Financials
22.4.14.4. Sales Footprint
22.4.14.5. SWOT Analysis
22.4.14.6. Strategy Overview
22.4.14.6.1. Marketing Strategy
22.4.14.6.2. Product Strategy
22.4.14.6.3. Channel Strategy
22.4.15. Atlas Medical UK
22.4.15.1. Overview
22.4.15.2. Product Portfolio
22.4.15.3. Key Financials
22.4.15.4. Sales Footprint
22.4.15.5. SWOT Analysis
22.4.15.6. Strategy Overview
22.4.15.6.1. Marketing Strategy
22.4.15.6.2. Product Strategy
22.4.15.6.3. Channel Strategy
22.4.16. TaiDoc Technology Corporation
22.4.16.1. Overview
22.4.16.2. Product Portfolio
22.4.16.3. Key Financials
22.4.16.4. Sales Footprint
22.4.16.5. SWOT Analysis
22.4.16.6. Strategy Overview
22.4.16.6.1. Marketing Strategy
22.4.16.6.2. Product Strategy
22.4.16.6.3. Channel Strategy
22.4.17. Drägerwerk AG & Co. KGaA
22.4.17.1. Overview
22.4.17.2. Product Portfolio
22.4.17.3. Key Financials
22.4.17.4. Sales Footprint
22.4.17.5. SWOT Analysis
22.4.17.6. Strategy Overview
22.4.17.6.1. Marketing Strategy
22.4.17.6.2. Product Strategy
22.4.17.6.3. Channel Strategy
22.4.18. F. Hoffmann-La Roche Ltd
22.4.18.1. Overview
22.4.18.2. Product Portfolio
22.4.18.3. Key Financials
22.4.18.4. Sales Footprint
22.4.18.5. SWOT Analysis
22.4.18.6. Strategy Overview
22.4.18.6.1. Marketing Strategy
22.4.18.6.2. Product Strategy
22.4.18.6.3. Channel Strategy
22.4.19. Sensing Self
22.4.19.1. Overview
22.4.19.2. Product Portfolio
22.4.19.3. Key Financials
22.4.19.4. Sales Footprint
22.4.19.5. SWOT Analysis
22.4.19.6. Strategy Overview
22.4.19.6.1. Marketing Strategy
22.4.19.6.2. Product Strategy
22.4.19.6.3. Channel Strategy
22.4.20. PTE. Ltd
22.4.20.1. Overview
22.4.20.2. Product Portfolio
22.4.20.3. Key Financials
22.4.20.4. Sales Footprint
22.4.20.5. SWOT Analysis
22.4.20.6. Strategy Overview
22.4.20.6.1. Marketing Strategy
22.4.20.6.2. Product Strategy
22.4.20.6.3. Channel Strategy
22.4.21. Atomo Diagnostics
22.4.21.1. Overview
22.4.21.2. Product Portfolio
22.4.21.3. Key Financials
22.4.21.4. Sales Footprint
22.4.21.5. SWOT Analysis
22.4.21.6. Strategy Overview
22.4.21.6.1. Marketing Strategy
22.4.21.6.2. Product Strategy
22.4.21.6.3. Channel Strategy
22.4.22. Mankind Pharma
22.4.22.1. Overview
22.4.22.2. Product Portfolio
22.4.22.3. Key Financials
22.4.22.4. Sales Footprint
22.4.22.5. SWOT Analysis
22.4.22.6. Strategy Overview
22.4.22.6.1. Marketing Strategy
22.4.22.6.2. Product Strategy
22.4.22.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
At-home Molecular Testing Market
